Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response. Long-term follow-up data offer valuable ...

Drug interactions, patient characteristics, and steroid use are critical in LN management, influencing treatment choices and outcomes. Nephrologists focus on renal preservation, while ...

Annually, we detail our impact as we move ever closer to cure lupus and bring relief and help to millions. We take seriously our responsibility to the lupus community. Our mission is to END LUPUS. Now ...

The Lupus Research Institute (LRI) today announced the first $1 million research grants given to lupus investigators by a private research organization. The LRI Distinguished Innovator Initiative was ...

“We are thrilled to achieve this milestone that will provide access to LUPKYNIS in Japan, where there is a high rate of lupus nephritis among Japanese lupus patients. Our successful strategic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Paul Hoover, M.D., Ph.D., Brigham and Women’s Hospital Lupus nephritis is a severe kidney disease affecting many people with lupus and often leads to kidney failure. Dr. Hoover helped discover a ...

EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc ... in combination with mycophenolate mofetil (MMF) to treat lupus nephritis (LN). The Company’s collaboration partner, Otsuka ...

“We are thrilled to achieve this milestone that will provide access to LUPKYNIS in Japan, where there is a high rate of lupus nephritis among Japanese lupus patients. Our successful strategic ...